Evolus, Inc. (EOLS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$6.78
-0.37%
Mkt Cap $449.47M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$18.40
Range $13.00 – $27.00
Implied Upside
+171.4%
Consensus $18.40 vs current $6.78